Cyclin 3D structures
From Proteopedia
Jump to navigation
Jump to search
3D Structures of Cyclin3D Structures of Cyclin
Updated on 17-February-2025
{"openlevels":0}
- CYCA2
- 3my5, 2wpa, 2wxv, 2wih, 2wip, 3f5x, 3eoc, 3eid, 3ej1, 3dog, 3ddp, 3ddq, 3bht, 2v22, 2uue, 2i40, 2bkz, 2c5n, 2c5o, 2c5v, 2c5x, 2c5y, 2bpm, 2c4g, 1fvv, 2c6t – hCYCA2 +CDK2+inhibitor - human
- 3bhu, 3bhv, 2uzd, 2uzb, 2uze, 2uzl, 2uzn, 2uzo, 2iw6, 2iw8, 2iw9, 2g9x, 1oi9, 1oiu, 1oiy, 1ogu, 1p5e, 1pkd, 1h1p, 1h1q, 1h1r, 1h1s, 4cfx, 4cfv, 4cfu, 4cfm, 5nev, 5nev, 5lmk, 5cyi, 7b7s, 7mkx, 7qhl - hCYCA2 +CDK2 T160P+inhibitor
- 8bzo - hCYCA2 +CDK2 T160P+ p27 – Cryo EM
- 1fin, 5if1 - hCYCA2 +CDK2
- 1vyw - hCYCA2 C-terminal 175-432 + hCDK2
- 7luo - hCYCA2 + SKP2 N-terminal
- 1jst, 3tnw, 6sg4 - hCYCA2 +CDK2 T160P
- 1h24, 1h25, 1h26, 1h27, 1h28, 1gy3 - hCYCA2 +CDK2 T160P+peptide
- 4bck, 4bcm, 4bcn, 4bco, 4bcp, 4bcq, 4cfn, 4cfw, 6gva, 6guf, 6gue, 6guc, 6gub, 8b54 - hCYCA2 +CDK2 T160P + inhibitor
- 6ath - hCYCA2 +CDK2 T160P + cyclin-dependent kinase inhibitor
- 4fx3 - hCYCA2 +CDK2 + inhibitor
- 4eoi, 4eoj, 4eok, 4eol, 4eom, 4eon, 4eoo, 4eop, 4eoq, 4eor, 4eos, 6rij, 7ack - hCYCA2 C-terminal +CDK2 T160P + inhibitor
- 2cjm - hCYCA2 +CDK2 T160P Y15P
- 2cch - hCYCA2 +CDK2 T160P+ATP analog
- 4i3z, 4ii5 - hCYCA2 +CDK2 T160P+ADP + Mg
- 2cci - hCYCA2 +CDK2 T160P+CDC homolog
- 2wma, 2wmb, 2x1n, 2wev, 2wfy, 2whb, 1okv, 1okw, 1ol1, 1ol2, 1urc, 1qmz, 3qhw, 6p3w - hCYCA2 +CDK2+peptide
- 1jsu - hCYCA2 +CDK2 (mutant)+P27
- 6q6g, 6q6h – hCYCA2 in APC/C-CDC20-CDK2-CKS2 complex – Cryo EM
- 8bya – hCYCA2 + CDK2 + SKP1 + SKP2 + CKS1 + p27 - Cryo EM
- 7b5l – hCYCA2 + CDK2 + NEDD8 + cullin-1 + RBX1 + SKP1 + SKP2 + CKSHS1 + p27 + UBE2L3 + Ub + ARIH1 - Cryo EM
- 8roz – bCYCA2 + CDK2 + CDC25a – bovine - Cryo EM
- 3qhr, 3khw - CYCA2 + P33 protein kinase + CDK2 peptide – mouse
- 3my5, 2wpa, 2wxv, 2wih, 2wip, 3f5x, 3eoc, 3eid, 3ej1, 3dog, 3ddp, 3ddq, 3bht, 2v22, 2uue, 2i40, 2bkz, 2c5n, 2c5o, 2c5v, 2c5x, 2c5y, 2bpm, 2c4g, 1fvv, 2c6t – hCYCA2 +CDK2+inhibitor - human
- CYCA3
- CYCB1 or G2/mitotic-specific CYCB1
- 2b9r – hCYCB1 (mutant)
- 2jgz - hCYCB1 + CDK2
- 6gu4, 6gu3, 6gu2 – hCYCB1 + hCDK1 + inhibitor
- 5hq0, 4yc3, 4y72 – hCYCB1 + hCDK1 + CDK regulatory subunit 2
- 5lqf – hCYCB1 + hCDK1 + CDK regulatory subunit 2 + inhibitor
- 7nj0 – hCYCB1 + hCDK1 + CDK regulatory subunit 1 + separin – Cryo EM
- 8tar, 8tau – hCYCB1 in cyclosome complex – Cryo EM
- 9fh9 – hCYCB1 in nucleosome complex – Cryo EM
- 2b9r – hCYCB1 (mutant)
- CYCC
- 3rgf, 4g6l – hCYCC + CDK8
- 4f6s, 4f6u, 4f6w, 4f70, 4f7j, 4f7l, 4f7n, 4f7s, 5idp, 5idn, 5icp, 5i5z, 5hvy, 5hnb, 5hbj, 5hbh, 5hbe, 5fgk, 5cei, 5bnj, 5xqx, 5xs2, 6qtg, 6qtj, 6r3s, 6t41, 9h8c, 9h8s – hCYCC + CDK8 + inhibitor
- 6tpa – hCYCC + CDK8 + drug
- 8tq2, 8tqc – hCYCC + CDK8 + mediator of RNA polymerase transcription subunit 12,13 – Cryo EM
- 8tqw – hCYCC + CDK8 + mediator of RNA polymerase transcription complex– Cryo EM
- 3rgf, 4g6l – hCYCC + CDK8
- CYCCCL1
- CYCD
- CYCE1
- CYCF
- 9cb3 – hCYCF + SKP1 + E2F1 peptide – Cryo EM
- 9cb3 – hCYCF + SKP1 + E2F1 peptide – Cryo EM
- CYCH
- 1kxu, 1jkw – hCYCH
- 6o9l – hCYCH in transcription preinitiation complex – Cryo EM
- 8pyr – hCYCH + CDK7 + MAT1
- 6xbz, 8orm, 8p6w, 8p6x, 8p73, 8p75, 8p79 – hCYCH + CDK7 + MAT1 – Cryo EM
- 6xd3, 7b5o, 7b5q, 8p6v, 8p6z, 8p70, 8p71, 8p72, 8p74, 8p76, 8p77, 8plz, 8s0t – hCYCH + CDK7 + MAT1 + inhibitor – Cryo EM
- 8p78 – hCYCH + CDK7 + MAT1 + drug – Cryo EM
- 8p6y – hCYCH + CDK7 + MAT1 + ATPgS – Cryo EM
- 7nvr – hCYCH + hCDK7 in DNA polymerase complex – Cryo EM
- 1kxu, 1jkw – hCYCH
- CYCK
- 2i53 – hCYCK N-terminal
- 4un0 - hCYCK + CDK12 T160P
- 4cxa - hCYCK + CDK12 T160P + AMPPNP
- 5efq, 4nst - hCYCK + CDK13 T160P + ADP
- 7nxj - hCYCK + CDK13 T160P + inhibitor
- 4un0, 5acb, 6b3e, 6ckx, 7nxj, 7nxk - hCYCK +CDK12 T160P + inhibitor
- 6td3, 8bu1, 8bu2, 8bu3, 8bu4, 8bu5, 8bu6, 8bu7, 8bu9, [[[8bua]], 8bub, 8buc, 8bud, 8bue, 8buf, 8bug, 8buh, 8bui, 8buj, 8buk, 8bul, 8bum, 8bun, 8buo, 8bup, 8buq, 8bur, 8bus, 8but, 9fmr - hCYCK +CDK12 T160P+ DDB1 + inhibitor
- 2i53 – hCYCK N-terminal
- CYCT
- 3blh - hCYCT1 +CDK9
- 3blq - hCYCT1 +CDK9+ATP
- 4imy, 4or5, 4ogr - hCYCT1 +CDK9 TPO160 +AMP + AF4/MRF2 family member 4
- 5l1z - hCYCT1 +CDK9 TPO160 +AMP + AF4/MRF2 family member 4 + RNA
- 6cyt - hCYCT1 +CDK9 TPO160 +AMP + AF4/MRF2 family member 4 + TAT + RNA
- 3lq5, 3tn8, 3tnh, 3tni, 4bcf, 4bcg, 4bch, 4bci, 4bcj – hCYCT1 (mutant)+CDK9
- 3blr - hCYCT1 +CDK9+inhibitor
- 6gzh, 6z45, 7nwk, 8i0l - hCYCT1 TPO160 +CDK9+inhibitor
- 3my1, 4ec8, 4ec9, 6w9e, 8k5r - hCYCT1 (mutant)+CDK9 TPO160 +inhibitor
- 3mi9, 3mia - hCYCT1 +CDK9+ protein TAT
- 2w2h - CYCT1 + protein TAT + RNA – horse
- 2ivx – hCYCT2 (mutant)
- 3blh - hCYCT1 +CDK9
- CYC
- Viral CYC